Jiangsu Sinopep-Allsino Biopharmaceutical Company Description

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.

The company offers formulations, such as thymalfasin products for injection, eptifibatide injections, alogliptin benzoate tablets, and oseltamivir phosphate capsules; APIs and intermediates; and drugs for type 2 diabetes and obesity, and coronavirus.

It also provides pharmaceutical research, clinical, and registration services of drugs; and undertakes CDMO/CMO projects of small molecule chemical API and intermediates.

The company was founded in 2009 and is headquartered in Hangzhou, China.

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Country	China
Founded	2009
Industry	Biotechnology
Sector	Healthcare
Employees	1,545

Contact Details

Address: Building E Hangzhou, 311121 China
Phone	86 571 8867 1330
Website	sinopep.com.cn

Stock Details

Ticker Symbol	688076
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE1000051X5
SIC Code	2834